BPA Call 75F40122A00008-75F40122F19007
Award Date
8/3/22
Potential Completion Date
4/4/25
Potential Value
$1.9M
Federal Agency
Food and Drug Administration
Awardee
Booz Allen Hamilton Inc.
Ultimate Awardee
Booz Allen Hamilton Holding Corporation
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Labor Hours
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Food and Drug Administration (FDA) awarded a Blanket Purchase Agreement (BPA) to Booz Allen Hamilton Inc., a leading provider of management, technology, and engineering services. The $149 million BPA is for organizational change management and business modernization support services. This BPA supports the FDA's efforts to enhance its operations and administration. Booz Allen Hamilton Inc. has an extensive history of providing professional services to various federal agencies through...
The U.S. Food and Drug Administration (FDA) awarded a Blanket Purchase Agreement (BPA) call worth up to $4,750,157.46 to Booz Allen Hamilton Inc. for a "Pharmaceutical Quality and Compliance Platform." This contract is under the Mission Oriented Business Integrated Services (MOBIS) Schedule, which is a General Services Administration (GSA) contract vehicle. The contract is for labor hours and does not have a set-aside designation. Booz Allen Hamilton Inc., a leading management,...
This contract was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Booz Allen Hamilton Inc., a leading management, technology, and engineering services provider to the U.S. government. The $1,965,088.49 Firm Fixed Price delivery order supports the development of an opioid systems modeling policy tool, which is part of the FDA's CDER PRIORITY ANALYSIS major program. The contract is not designated as a set-aside. Booz Allen Hamilton Inc. has an extensive...
This is a $9,183,143.60 Blanket Purchase Agreement (BPA) Call contract awarded by the Food and Drug Administration (FDA) to Booz Allen Hamilton Inc. for system development, modernization, and enhancement support services. The contract is not set-aside and utilizes the Multiple Award Schedule (MAS) contract vehicle. Booz Allen Hamilton is a leading provider of management, technology, and engineering services to the U.S. government, with expertise in defense, intelligence, and civil markets. The...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a Blanket Purchase Agreement (BPA) call contract to Booz Allen Hamilton Inc. for DRUG QUALITY AND SECURITY SERVICES - DQSA. The $10,600,837.15 contract, which has a completion date of July 15, 2020, was awarded on July 16, 2019 under the General Services Administration's (GSA) Professional Services Schedule (PSS). The contract is for labor hours services and does not have a set-aside designation. Booz...
This federal contract award, valued at $698,423.41, was issued by the Food and Drug Administration (FDA) as a Blanket Purchase Agreement (BPA) call under the Multiple Award Schedule (MAS) contract vehicle. The contract was awarded to Booz Allen Hamilton Inc., a leading provider of management, technology, and engineering services to the U.S. government. The scope of this task order is to enhance an existing Agent-Based Model (ABM) by refining and calibrating it using real-world data from the City...
Booz Allen Hamilton Inc. was awarded a $3.9 million contract by the Department of Health and Human Services' Food and Drug Administration to provide advanced analytics capabilities supporting the agency's Opioids program. Under the terms of the labor-hours contract, which utilizes the contractor's Multiple Award Schedule vehicle and runs from July 2021 through September 2022, Booz Allen will analyze FDA data to help the agency combat the ongoing opioids crisis. No subcontractors or set aside...
This contract was awarded by the Food and Drug Administration (FDA) to Booz Allen Hamilton Inc., a leading management and technology consulting firm, to provide technical and management consulting services to support the planning and improvement of business operations across the FDA enterprise. The contract, valued at $660,671.10, is a Blanket Purchase Agreement (BPA) call under the Multiple Award Schedule (MAS) contract vehicle. The objective is to comprehensively support the FDA's business...
The Department of Health and Human Services Food and Drug Administration awarded a Blanket Purchase Agreement (BPA) call contract to Booz Allen Hamilton Inc. for business process improvement and strategic planning services. The contract has a potential value of $597,131.80 and was awarded on September 13, 2019, with a completion date of September 29, 2020. The contract is under the Mission Oriented Business Integrated Services (MOBIS) Federal Supply Schedule and uses a labor hours pricing...
This federal contract award from the Food and Drug Administration (FDA) is for the CDER Informatics Enterprise Service and Operation Modernization project. It is a $17,461,833.28 Blanket Purchase Agreement (BPA) call awarded to Booz Allen Hamilton Inc. under the Multiple Award Schedule (MAS) contract. The contract will provide informatics enterprise services and operations modernization support to the FDA's Center for Drug Evaluation and Research (CDER) over a 3-year period until January 2025....